State of Alaska Department of Revenue’s Ionis Pharmaceuticals IONS Stock Holding History

State of Alaska Department of Revenue’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,618	Closed	-$939K	–	1691
2019 Q2	$939K	Buy	14,618 +52	+0.4%	+$3.68K	0.02%	764
2019 Q1	$1.18M	Sell	14,566 -840	-5%	-$54.2K	0.02%	656
2018 Q4	$832K	Buy	15,406 +110	+0.7%	+$5.61K	0.02%	729
2018 Q3	$788K	Buy	15,296 +266	+2%	+$12.5K	0.01%	836
2018 Q2	$626K	Buy	15,030 +3,670	+32%	+$163K	0.01%	933
2018 Q1	$500K	Buy	11,360 +2,260	+25%	+$115K	0.01%	955
2017 Q4	$457K	Buy	+9,100	New	+$499K	0.01%	838

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State of Alaska Department of Revenue's IONS Position: Q3 2019 in Review

State of Alaska Department of Revenue sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 14,618 shares — an estimated $939K sold.

State of Alaska Department of Revenue first reported a position in IONS in Q4 2017 and held it in 7 quarters. The position peaked at $1.18M in Q1 2019. 370 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

State of Alaska Department of Revenue reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
State of Alaska Department of Revenue sold 14,618 Ionis Pharmaceuticals shares in Q3 2019, an estimated $939K.
State of Alaska Department of Revenue first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 7 quarters.
State of Alaska Department of Revenue's Ionis Pharmaceuticals position peaked at $1.18M in Q1 2019.
370 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2019, filed 2 Oct 2019.